The FDA could act soon on the first two, and more new drugs are in the works Novo Nordisk's obesity pill made it through the FDA first
The choice of GLP-1 medication depends on individual factors, and patients are advised to discuss their options with healthcare providers to create personalized treatment plans that effectively manage their condition
Research Recap: GLP-1 Access & Clinical Outcomes for Obesity Treatment Calibrate Article published on August 28, 2024 Medically Reviewed by Kristin Baier, MD Obesity and overweight significantly increase the risk of type-2 diabetes and other cardiometabolic diseases, making effective treatment crucial for overall health
[12] Ryu RJ, Hays KE, Hebert MF
Boost Brain Health One of the most exciting areas of research is the link between GLP-1 medications and brain health
Together, they address both the energy supply side and the inflammatory stress side of the neuronal resilience equation simultaneously